Location History:
- Penzberg, DE (2023)
- Berlin, DE (2000 - 2024)
Company Filing History:
3 out of 277 
1 out of 30 
1 out of 1 Years Active: 2000-2024
Title: Bernd Hinzmann: Innovator in Nucleic Acid Isolation and Cancer Prediction
Introduction
Bernd Hinzmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of molecular medicine, particularly in the isolation of nucleic acids and the prediction of cancer recurrence. With a total of 6 patents to his name, Hinzmann's work has the potential to impact both research and clinical practices.
Latest Patents
One of Hinzmann's latest patents is a system and method for the isolation and qualification of nucleic acids. This method involves isolating DNA from a source, resulting in a composition that includes the isolated DNA. The isolated DNA contains at least two target regions, with the second target region being longer than the first. The method also quantifies the total mass of the isolated DNA and calculates a Q-ratio, which is essential for preparing the DNA for sequencing. Another significant patent is a non-invasive test designed to predict the recurrence of colorectal cancer in patients post-surgery. This method analyzes circulating tumor DNA from a patient's sample, providing valuable insights for patient management.
Career Highlights
Throughout his career, Bernd Hinzmann has worked with prominent organizations such as Roche Sequencing Solutions, Inc. and the Max Delbrück Center for Molecular Medicine. His experience in these institutions has allowed him to develop innovative solutions that address critical challenges in molecular diagnostics.
Collaborations
Hinzmann has collaborated with esteemed colleagues, including Horst Will and Sophie Beckert. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies in the field.
Conclusion
Bernd Hinzmann's contributions to the fields of nucleic acid isolation and cancer prediction exemplify the impact of innovative thinking in medicine. His patents and collaborations continue to pave the way for advancements that can improve patient outcomes.